Blog
RSS FeedPosted by Michael Wonder on 14 Nov 2017
Proposal to fund HIV pre-exposure prophylaxis (PrEP)
14 November 2017 - PHARMAC is seeking feedback on a proposal to widen funded access to emtricitabine with tenofovir disoproxil fumarate ...
Posted by Michael Wonder on 09 Nov 2017
'Mind the gap' revisited
6 November 2017 - John Zalcberg and I note with interest the article by Evans et al recently published in ...
Posted by Michael Wonder on 09 Nov 2017
Decision to fund zoster vaccine
9 November 2017 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe & Dohme to ...
Posted by Michael Wonder on 08 Nov 2017
Proposal to list methylnaltrexone bromide
8 November 2017 - PHARMAC is seeking feedback on a proposal to list methylnaltrexone bromide (Relistor) 12 mg/0.6 mL injection in ...
Posted by Michael Wonder on 31 Oct 2017
Fund for next generation medicines investigated
1 November 2017 - A fund to give Kiwis quicker access to new-generation medicines will be investigated by the Government, ...
Posted by Michael Wonder on 31 Oct 2017
New Zealand Pharmaceutical Schedule - 1 November 2017
1 November 2017 - The November 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2017
Proposal to widen access to zoledronic acid for early breast cancer
31 October 2017 - PHARMAC proposes to widen funded access to zoledronic to include adjuvant use in post-menopausal women with ...
Posted by Michael Wonder on 26 Oct 2017
Call for anti-HIV drug to be funded
26 October 2017 - The AIDS Foundation says it's a fiscal no-brainier to fully fund a drug that prevents the ...
Posted by Michael Wonder on 24 Oct 2017
Hundreds of people with diabetes are set to benefit from the funding of a new treatment that will help prevent blindness
24 October 2017 - From 1 November 2017 dexamethasone implants (brand name Ozurdex) will be funded for eligible people with ...
Posted by Michael Wonder on 23 Oct 2017
Health care underfunded for too long
23 October 2017 - The death of an elderly man - who broke his hip and died after surgery was ...
Posted by Michael Wonder on 13 Oct 2017
Decision to fund dexamethasone implants (Ozurdex)
13 October 2016 - PHARMAC is pleased to announce the approval of an agreement with Allergan for the listing of ...
Posted by Michael Wonder on 12 Oct 2017
Missing out on cancer drugs
12 October 2017 - A letter to the Editor of the New Zealand Herald from the Managing Director of MSD ...
Posted by Michael Wonder on 06 Oct 2017
Agreements for the supply of orthopaedic implants and associated products
6 October 2017 - PHARMAC is pleased to announce the approval of agreements with Medtronic New Zealand Limited (“Medtronic”) and ...
Posted by Michael Wonder on 04 Oct 2017
Proposal to list a range of medical thermometer products and medical devices used in the prevention of venous thromboembolisms supplied by Medtronic
4 October 2017 - PHARMAC is seeking feedback on a proposal to list a range of medical thermometer and venous thromboembolism ...
Posted by Michael Wonder on 02 Oct 2017
Why is Keytruda funded for melanoma, but not lung cancer?
1 October 2017 - Is it fair that melanoma gets funded for a particular drug while lung cancer doesn't? ...